Crossmark

Microencapsulated docosahexaenoic acid increases the Omega-3 Index and attenuates the physiological impact of eccentric exercise in physically trained adults: a 12-week double-blind placebo-controlled trial

Crossref DOI link: https://doi.org/10.1007/s00394-026-03998-6

Published Online: 2026-05-29

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anthony, Ryan https://orcid.org/0000-0002-2233-8614
Macartney, Michael J. https://orcid.org/0000-0001-7265-5725
McLennan, Peter L. https://orcid.org/0000-0003-0252-8039
Elhage, Amal https://orcid.org/0000-0003-0625-3183
Sluyter, Ronald https://orcid.org/0000-0003-4909-686X
Sampson, John A. https://orcid.org/0000-0002-6800-7757
Mitchell, Todd W. https://orcid.org/0000-0002-1372-9963
Peoples, Gregory E. https://orcid.org/0000-0002-8279-1787
Funding

Funding for this research was provided by:

The University of Wollongong
License Information

Text and Data Mining valid from 2026-05-29

Version of Record valid from 2026-05-29
More Information

Article History

Received: 4 May 2025

Accepted: 9 May 2026

First Online: 29 May 2026

Declarations

:

: The authors declare that they have no conflict of interest.